This article presents a dynamic model that quantifies the temporal evolution of the concentration and oxygen saturation of hemoglobin in tissue, as determined by time-varying hemodynamic and metabolic parameters: blood volume, flow velocity, and oxygen consumption. This multi-compartment model determines separate contributions from arterioles, capillaries, and venules that comprise the tissue microvasculature, and treats them as a complete network, without making assumptions on the details of the architecture and morphology of the microvascular bed. A key parameter in the model is the effective blood transit time through the capillaries and its associated probability of oxygen release from hemoglobin to tissue, as described by a rate constant for oxygen diffusion. The solution of the model in the time domain predicts the signals measured by hemodynamic-based neuroimaging techniques such as functional near-infrared spectroscopy (fNIRS) and functional magnetic resonance imaging (fMRI) in response to brain activation. In the frequency domain, the model yields an analytical solution based on a phasor representation that provides a framework for quantitative spectroscopy of coherent hemodynamic oscillations. I term this novel technique coherent hemodynamics spectroscopy (CHS), and this article describes how it can be used for the assessment of cerebral autoregulation and the study of hemodynamic oscillations resulting from a variety of periodic physiological challenges, brain activation protocols, or physical maneuvers.
Introduction
Models for hemodynamic-based neuroimaging studies fall under either one or both of two categories. The first category includes models that characterize the features and physiological relationships among the hemodynamic and metabolic perturbations associated with brain activation [namely cerebral blood flow (CBF), cerebral blood volume (CBV), and metabolic rate of oxygen (CMRO 2 )] as well as the pathways linking them to neural activity. The second category includes models that specify and quantify the relationship between a given set of activation-induced perturbations in CBF, CBV, and CMRO 2 , and the quantities or signals measured by a particular neuroimaging technique (for example, the tissue concentrations of oxy-hemoglobin and deoxyhemoglobin measured with functional near-infrared spectroscopy (fNIRS), or the blood oxygenation level dependent (BOLD) signal measured with fMRI). The dynamic model presented in this article falls under the second category.
Modeling cerebral hemodynamics and tissue oxygenation is a challenging task because of the various interconnected contributions from blood flow velocity distributions and oxygen transport within the vasculature, oxygen diffusion between the microvascular space and tissue, cerebral autoregulation, active and passive vascular compliance effects, individual contributions from multiple vascular compartments, etc. Successful approaches should identify a set of key parameters that reproduce the salient features of signals measured with neuroimaging techniques, while providing a necessarily simplified description of the dynamic features of the brain vasculature, blood flow, and oxygen delivery to tissue. An example of such a successful approach is the dynamic balloon model (Buxton et al., 1998 ), a pioneering model based on just three parameters: the oxygen extraction factor (and its dependence on flow based on the oxygen limitation model; Buxton and Frank, 1997) , the mean blood transit time through the venous compartment, and the exponent in the power law relationship between volume and flow (with some flexibility to account for a slow volume recovery after activation). The balloon model predicts the BOLD response on the basis of the activation-induced perturbation in CBF, it is consistent with experimental results (Buxton et al., 1998; Mildner et al., 2001; Toronov et al., 2003) , and accounts for nonlinear features of evoked brain responses (Friston et al., 2000) . Another pioneering contribution is a windkessel model based on similar ideas (delayed venous compliance) built on a biophysical model of blood flow driven by arterial blood pressure through a resistive and compliant vasculature (Mandeville et al., 1999a) . A steady state deoxy-hemoglobin dilution model was also proposed in the late 1990s to derive a relationship between the BOLD signal, CBF and CMRO 2 (Hoge et al., 1999) . A series of refined, modified, and extended models have been developed over the past decade with growing levels of complexity and sophistication, in an attempt to better describe the complicated underlying physiology of brain activation, and to quantify the effects of physiological and metabolic parameters on the signals measured with neuroimaging techniques. For example, multi-compartment versions of the balloon and windkessel models have been developed to include contributions from the arterial compartment (Blockley et al., 2009) , from a serial (Huppert et al., 2007; Payne, 2006; Zheng et al., 2005) or network (Boas et al., 2008) combination of arterial, capillary and venous compartments, and to account for cerebral autoregulation (Diamond et al., 2009; Payne, 2006; Payne et al., 2009 ). Quasi-static models for the tissue concentration and saturation of hemoglobin have been developed on the basis of blood flow velocity and the rate of oxygen diffusion from blood vessels (Fantini, 2002; Kocsis et al., 2006) . While many of these models, at least initially, were specifically aimed at predicting/ interpreting fMRI data, and therefore focused on deoxy-hemoglobin and blood volume with a special emphasis on the venous compartment, any approach aimed at modeling the tissue concentration and oxygen saturation of hemoglobin is directly relevant to both fMRI and fNIRS. Major differences between the two techniques are the voxel size (linear dimensions: 1-4 mm for fMRI, 10-30 mm for fNIRS) and the fact that fNIRS is highly sensitive to both oxygenated and deoxygenated hemoglobin (since they both feature significant absorption in the nearinfrared) while fMRI is sensitive only to the paramagnetic deoxygenated form of hemoglobin. However, both techniques are sensitive to changes in cerebral blood volume and hemoglobin saturation, and the model presented here is therefore relevant to both fNIRS and fMRI.
Near-infrared spectroscopy (NIRS) affords non-invasive measurements of the concentrations of deoxy-hemoglobin and oxy-hemoglobin in macroscopic (~1-10 cm 3 ) tissue volumes, and can be applied to functional studies of the human brain (fNIRS) (Ferrari and Quaresima, 2012; Lloyd-Fox et al., 2010; Wolf et al., 2008) . Translating diffuse optical intensity measurements into hemoglobin concentrations is typically based on the assumption of a spatially uniform hemoglobin distribution within the optically probed tissue volume, so that optical measurements of hemoglobin concentration and saturation reflect some weighted average of the contributions from various vascular compartments in tissues. In functional magnetic resonance imaging (fMRI), the BOLD signal is a weighted average of extravascular signals (resulting from susceptibility differences between blood vessels and surrounding tissue) and intravascular signals (resulting from the concentration of deoxy-hemoglobin in blood), and depends on the blood volume and blood oxygenation in the tissue considered (Obata et al., 2004) .
A first issue to consider is the impact on NIRS measurements of hemoglobin localization in blood vessels. It was proposed that an empirical volume-weighted sum of contributions from multiple blood vessels can account for measured optical signals in tissues (Liu et al., 1995) . Diffusion theory and Monte Carlo simulations have shown that for smaller blood vessels (d b 0.06/μ a (small vessel) , where d is the blood vessel diameter and μ a (small vessel) is the absorption coefficient of blood in small blood vessels) the assumption of a homogeneous distribution of hemoglobin in tissue is valid (Firbank et al., 1997) . The near-infrared absorption of blood in the microvasculature results from: the blood hemoglobin concentration (~2.3 mM), the molar extinction coefficient of hemoglobin (~2 cm −1 /mM at the isosbestic point of 800 nm; Matcher et al., 1995) , and the reduced hematocrit in arterioles and capillaries (by as much as 30% in the cerebral vasculature; Lammertsma et al., 1984) per the Fårhaeus effect. As a result, μ a (small vessel)~3 .2 cm −1 and the assumed homogeneous distribution of hemoglobin holds for blood vessels that are smaller than~200 μm in diameter. The contribution of larger blood vessels to the overall blood volume in tissue tends to be underestimated by diffuse optical measurements in tissue (Firbank et al., 1997) . However, it was reported that the oscillatory displacement and pulsation of blood vessels as large as 1 mm in diameter result in optical spectra that reflect the optical properties of blood within the oscillating blood vessels rather than the background tissue (Chen et al., 2010) . As a result, dynamic diffuse optical measurements can be quantitatively associated with the optical properties of blood in larger vessels (this latter result accounts for the feasibility of pulse oximetry for arterial saturation measurements). One can therefore assume that individual vascular compartments contribute to the NIRS signals proportionally to their volume fraction, in general for the microvasculature (d ≲ 200 μm) and for larger blood vessels (d ≲ 1 mm) in the case of dynamic perturbations (vascular dilation, contraction, displacement, etc.) . A second issue to consider is associated with the longitudinal variation of hemoglobin saturation and hematocrit in the microvasculature. In fact, oxygen diffusion from arterioles and capillaries to parenchymal tissue accounts for a longitudinal oxygen gradient in the microvasculature, while the network Fårhaeus effect results in a reduced hematocrit in the microvascular network compared to the hematocrit of the incoming blood (Pries et al., 1986) . Since the lengths of arteriolar and capillary branches [~300-1000 μm in humans (Guyton and Hall, 2011 (Ch. 14) ) and~400 μm in the rat mesentery (Pries et al., 1995) ] are shorter than the linear size of the optically probed volume (~cm) and fMRI voxels (~mm), it is appropriate to consider average levels of longitudinal oxygenation, hematocrit, and oxygen delivery to tissue when modeling NIRS and fMRI measurements. These average levels are more appropriately termed effective values since they reflect further complex processes such as uneven partitions of erythrocytes and plasma at bifurcations (resulting in heterogeneous vessel hematocrit), arteriovenous shunting, cross-diffusion of oxygen between adjacent microvessels, greater velocity of red blood cells than plasma in the microvasculature, etc. One must also consider contributions from larger arterioles and venules, where blood flow has different properties than in capillaries, for example because of pulsatile effects (in arterioles) and faster flow velocity.
A quantitative summary of morphological (diameter, length) and functional (flow velocity, tube hematocrit) properties of rat mesentery microvasculature is reported in Table 1 (Pries and Secomb, 2008) . The tube hematocrit represents the volume concentration of red blood cells within small blood vessels, which is lower than the hematocrit of blood entering or leaving the microvascular network (discharge hematocrit) because of the Fåhraeus effect. The size and morphology of cortical arteries (40-280 μm in diameter) and veins (30-380 μm in diameter) in the human brain have been studied postmortem by intravascular injection of India ink (Duvernoy et al., 1981) . A similar method, refined by the introduction of confocal microscopy and 3D digital morphometry, has led to statistical distributions of diameter and length of vascular segments in the human cerebral cortex, resulting in capillary diameters of 6.5 ± 1.7 μm and capillary lengths of 53 ± 50 μm (Lauwers et al., 2008) . A number of animal studies on the cat and rat brain have reported capillary diameters of 2.5-8.8 μm (Hudetz et al., 1993; Motti et al., 1986; Pawlik et al., 1981; Schlageter et al., 1999) , and segment lengths of 10-300 μm (Hudetz et al., 1993; Motti et al., 1986) . Capillary flow velocity was found to be highly variable among capillaries within the range of 0.4-3.9 mm/s (median: 1.5 mm/s) in the cat cortex (Pawlik et al., 1981) , and 0.77-2.22 mm/s (mean: 1.56 mm/s) in the rat cortex (Hudetz et al., 1993) . Therefore, the reference values reported in Table 1 , which are based on a systematic study on a large number of vascular segments on multiple microvascular networks in the rat mesentery, appear to be representative also of the cerebral microvasculature, with the possible exception of the shorter capillary lengths observed in the brain cortex. However, given the net-like structure of capillaries (Cassot et al., 2006) , one needs to consider the total capillary length over which oxygen diffusion from blood to tissue occurs, which is longer than the individual capillary segment length of 53 μm reported in (Lauwers et al., 2008) . Finally, the blood volume fraction in brain tissue was found to be~1-1.5% for capillaries and~2-4% for the entire vasculature, depending on cortical depth (Cassot et al., 2006) , so that it is reasonable to assume volume fractions in the order of 0.015 for capillaries and 0.005 for both arterioles and venules.
This article presents a dynamic model that builds on my previous quasi-static model (Fantini, 2002) to relate tissue concentration and saturation of hemoglobin to hemodynamic (i.e., blood volume, flow velocity) and metabolic (i.e., oxygen consumption) processes involving different vascular compartments. Rather than applying a mass conservation equation to relate blood inflow, outflow, and volume as done in the balloon and windkessel models (Buxton et al., 1998; Mandeville et al., 1999a) , I have considered blood volume, flow velocity, and rate of oxygen extraction as independent variables, and I have developed a dynamic model that specifies the hemoglobin saturation as a function of time and longitudinal coordinate along a blood vessel. This approach does not attempt to specify the relationship between CBF, CBV, and CMRO 2 , which is left to physiological models (for example, I use here the high-pass model that relates flow velocity changes to blood pressure changes in cerebral autoregulation), but it affords a dynamic analysis of the tissue concentration and saturation of hemoglobin in response to given perturbations in CBF, CBV, and CMRO 2 . In particular, I have introduced a phasor representation that allows for the quantitative analysis of periodic hemodynamic oscillations (ideally sinusoidal) that may arise from the heart beat, respiration, spontaneous lowfrequency oscillations, or from a variety of periodic stimulation protocols, physiological challenges, or physical maneuvers. Such quantitative analysis leads to a novel approach to the study of tissue hemodynamics that I name coherent hemodynamics spectroscopy (CHS). This model also yields a time-domain solution that allows for the derivation of tissue concentration and saturation of hemoglobin in response to arbitrary perturbations in blood volume (independently in the arterial, capillary, and venous compartments), capillary flow velocity, and oxygen consumption. The multi-compartment analysis presented here treats the arterial, capillary, and venous compartments as a complete vascular network without the need to define morphological and functional details beyond the effective blood transit times in capillaries and venules, and the rate constant of oxygen extraction from the blood in the capillaries.
Hemodynamic model

Nomenclature
The relevant hemoglobin-related quantities modeled here are the average volume concentrations of deoxy-hemoglobin, oxy-hemoglobin, and total (oxy + deoxy) hemoglobin in tissue, and the average oxygen saturation of hemoglobin in tissue. These four quantities are indicated with D, O, T, and S, respectively. Superscripts in parentheses indicate partial contributions from a specific vascular compartment, namely (a) arterial, (c) capillary, and (v) venous. Note that a lack of superscript indicates average tissue concentrations or saturation. Here, the arterial compartment includes arteries and larger arterioles (diameter >40 μm) that are characterized by pulsatile blood flow and negligible oxygen diffusion to tissue (Tsai et al., 2003) ; the capillary compartment refers to the microvasculature involved in oxygen diffusion to tissue, which in addition to the capillaries also includes smaller arterioles (diameter b 40 μm) (Tsai et al., 2003) ; the venous compartment includes venules and veins which are not involved with oxygen diffusion to tissue. A schematic representation of the blood vasculature and its decomposition into arterial, capillary, and venous compartments is presented in Fig. 1 , T (c) , T (v) : contributions to T from the arterial, capillary, venous compartments (mol HbT /l tissue ); S = O / T: average tissue saturation;
: average arterial saturation; 〈S
: average capillary saturation;
: average venous saturation; ctHb:
concentration of total hemoglobin in blood (mol HbT /l blood ); ϕ (a) , ϕ (c) , ϕ (v) : volume fractions of arterial, capillary, and venous blood in tissue (ml blood /ml tissue ); Ƒ (c) :
Fåhraeus factor (ratio of capillary to large vessel hematocrit).
It must be noted that D
, and T ( ) (where the empty parentheses in the superscripts refer to any vascular compartment) represent concentrations in tissue, so that they are given by the corresponding concentrations in blood (ctHb for total hemoglobin) multiplied by the volume fraction ϕ ( ) (or Ƒ 
, ϕ (c) , and ϕ (v) are considered as steady state, constant volume fractions (i.e., baseline, initial, or average values). From these definitions, it follows that: , and ϕ (v) , respectively. effective combined length of small arterioles and capillaries (mm); L (v) :
effective combined length of venules (mm);
: blood transit time in capillaries (s);
/c (v) : blood transit time in venules (s); α _ O : rate constant of oxygen diffusion from blood to tissue (s
−1
).
The rate constant of oxygen diffusion to tissue α _ O is proportional to the metabolic rate of oxygen ( _ O) through the oxygen solubility in tissue and the microvascular partial pressure of oxygen (Secomb et al., 1993) . The time dependence of blood volume, flow velocity, and oxygen consumption is described by the temporal changes in these quantities normalized to their baseline values (i.e., (x − x 0 ) / x 0 where x represents volume, flow velocity, or oxygen consumption, and x 0 represents the baseline value). ; Table 1 Length, diameter, flow velocity, and tube hematocrit measured in microvessel networks of the rat mesentery (Pries and Secomb, 2008 ), and venous (v (v) ) volume changes are considered separately. The model shows that changes in the arterial and venous flow velocities do not affect the tissue concentration and saturation of hemoglobin, so that only f (c) is considered. Oxygen consumption changes are directly associated solely with the capillary compartment, so that no superscripts in _ o are introduced. With these notations, denoting the tissue volume of interest with V, the time-dependent blood volume fractions for the arterial, capillary, and venous compartments are:
(t)]: time-varying venous blood volume fraction.
We have recently introduced phasor notation to describe sinusoidal oscillations of the tissue hemoglobin concentration at angular frequency ω (Zheng et al., 2010 
From the definition of 〈S〉 V (which, for in-phase volume oscillations of arterial, capillary, and venous compartments, is a weighted average of S |/|T|) and considering that, in general, flow velocity and oxygen consumption changes are not associated with changes in the total hemoglobin concentration (Fantini, 2002) , it follows that:
For small oscillations, which are often associated with periodic physiological perturbations of interest, it is shown in Appendix A that:
I also introduce phasors that describe the sinusoidal oscillations of blood volume, flow velocity, and oxygen consumption at a given angular frequency ω. Their direction indicates the phase of the associated oscillations, and their magnitude is the amplitude of the oscillations normalized to the average value. Consequently, the blood volume, flow velocity, and oxygen consumption phasors are all dimensionless. capillary flow velocity phasor;
oxygen consumption phasor. Table 2 reports the set of representative values of key parameters that have been used to obtain quantitative predictions of the model. Throughout the manuscript, the values of Table 2 are used to estimate predictions of the model unless otherwise specified.
Arterial compartment
Because the arterial compartment is not involved in the diffusion of oxygen to tissue, it does not feature a longitudinal oxygen gradient and it is unaffected by changes in flow velocity and oxygen consump-
Arterial Venous Capillary Blood vasculature Fig. 1 . Schematic representation of the blood vasculature, including its decomposition into arterial (arteries, larger arterioles), capillary (smaller arterioles, capillaries), and venous (venules, veins) compartments. Small arterioles (b40 μm) are included within the capillary compartment because they are involved together with capillaries with oxygen out-diffusion to tissue. The topological structure of capillaries is net-like, while that of cerebral arterioles and venules is tree-like (Cassot et al., 2006) .
where Eq. (6) has been used to derive Eq. (10). Eqs. (7) and (8) reflect the approach to arterial saturation measurements by pulse oximetry (Wukitsch et al., 1988) .
Capillary compartment
The vascular compartment from which the diffusion of oxygen to tissue occurs (small arterioles and capillaries) is the one in which the interplay between blood flow velocity and oxygen consumption induces changes in the blood concentrations of oxy-hemoglobin and deoxy-hemoglobin. The total concentration of hemoglobin, according to Eq. (5), is only affected by volume changes, so that:
Changes in the capillary blood volume can be associated with dilation/contraction of the microvasculature, and/or by capillary recruitment/derecruitment. However, capillary recruitment may not play a significant role in the brain (Gobel et al., 1989) .
Delivery of oxygen to the tissue involves convective transport through blood flow in the vasculature, release of oxygen from hemoglobin to the plasma, and diffusion down an oxygen tension gradient from the plasma to the tissue. If we indicate with [O 2 ] in and [O 2 ] out the upstream and downstream concentrations of oxygen in the blood, the rate of oxygen extraction ( _ O 2 ) from a capillary can be expressed as the product of the convective inflow of oxygen (σc (c) [O 2 ] in , where σ is the cross sectional area of the blood vessel and c (c) is the speed of blood flow in the capillary) times the oxygen extraction factor
Because 97-98% of the oxygen in blood is bound to hemoglobin (Guyton and Hall, 2011 (Ch. 40); McLellan and Walsh, 2004) , [O 2 ] in~4 S in ctHb, where S in is the saturation of incoming blood, ctHb is the total hemoglobin concentration in blood, and the factor 4 takes into account the four binding sites for oxygen of hemoglobin. By introducing a probability of oxygen extraction from blood per unit time (κ), which depends on the capillary wall permeability (Buxton and Frank, 1997) and the oxygen tension gradient across the capillary wall (Hyder et al., 1998) , one can define a rate constant for oxygen diffusion to tissue α _ O = κr, where r is the ratio of plasma-to-blood oxygen content (Buxton and Frank, 1997; Hyder et al., 1998; Zheng et al., 2002) . Even though r is not strictly constant along the capillary length, its variability can be neglected in the evaluation of the profile of the oxygen concentration in blood along the capillary length (Zheng et al., 2002) . Therefore, the oxygen saturation of hemoglobin, which is equal to the arterial saturation S (a) as blood enters the capillary compartment, decays exponentially over the capillary length ' (Fantini, 2002) :
and the average capillary saturation over the total capillary length L
is given by (Fantini, 2002) :
so that:
where I have introduced the blood transit time in capillaries t (c) =
. Eq. (14) takes into account the fact that there is no delay or phase difference between changes in blood volume and changes in the tissue concentration of oxy-hemoglobin (because they are just proportional to each other).
The situation is different for changes in blood flow velocity and oxygen consumption, since they induce delayed changes in the tissue concentration of oxy-hemoglobin due to the blood transit time in the capillaries. By considering the vascular network as a linear and timeinvariant system, which may be justified for relatively small hemodynamic perturbations and for measurements over relatively short periods of time, one can model the frequency dependence of the hemodynamic phasors defined above by means of transfer functions.
The response of the average capillary saturation to a step change in the capillary blood flow velocity is derived in Appendix B and results in an RC-like low-pass response with time constant τ (c) = t 
As discussed in Appendix D, the transfer function of Eq. (15) also applies to a saturation response to oscillations in the oxygen consumption rate. For small flow velocity oscillations, one can use this transfer function, together with the steady state capillary saturation ) and oxygen consumption rate Fantini, 2002) , to obtain the frequency dependence of capillary saturation phasors associated with flow velocity and oxygen consumption oscillations:
Venous compartment
The total concentration of hemoglobin is only affected by volume changes [see Eq. (5)], so that:
Changes in the venous blood volume can be associated with dilation/contraction of the venules and veins.
The oxygen saturation of hemoglobin, which is equal to the arterial saturation S (a) at the entrance of the capillary and decays exponentially along the capillary, takes the following value at the end of the capillary length L
, which is the venous saturation S (v) (Fantini, 2002) :
Consequently:
/c (c) is the blood transit time in capillaries. The response of the average venous saturation to step changes in the capillary and venule blood flow velocities is derived in Appendix C, and results in a time-shifted Gaussian low-pass response with rise time t r (v)~0 .6(t (c) + t (v) ) and temporal shift t 0.5
). Here, 
where the factor 0.281 in Eq. (26) results from the fact that the cutoff angular frequency of the Gaussian low-pass filter is given by ω c
)]. As discussed in Appendix D, the transfer function of Eq. (26) also applies to a saturation response to oscillations in the oxygen consumption rate. For small flow velocity oscillations, one can use this transfer function, together with the steady state venous saturation changes resulting from relative changes in capillary flow velocity (Δc (c) /c (c) ) and oxygen consumption rate Fantini, 2002) , to obtain the frequency dependence of the venous saturation phasors associated with flow velocity and oxygen consumption oscillations: where
is the steady state change in venous saturation due to capillary flow velocity (+ sign) and oxygen consumption (− sign) changes. The phasor components of tissue concentrations of oxy-hemoglobin and deoxy-hemoglobin due to flow velocity and oxygen consumption oscillations are therefore given by:
The phasors of tissue concentrations of oxy-hemoglobin and deoxy-hemoglobin result from the superposition of contributions from blood volume, flow velocity, and oxygen consumption oscillations, whereas the hemoglobin saturation phasor can be obtained by using Eq. (6):
Combination of contributions from arterial, capillary, and venous compartments
By recalling that the concentration of hemoglobin in tissue is given by the concentration of hemoglobin in blood times the volume fraction of the vascular compartment of interest, with the additional Fåhraeus factor for the capillary compartment [see Eq. (1)], one can write the following expressions for the tissue concentrations and saturation phasors:
It is worth observing that the partial volumes ϕ
, ϕ
, and ϕ , ϕ
, and ϕ (v) to take this into account.
Implications of the model
The dynamic model presented here provides a quantitative description of the changes in the concentrations of deoxy-hemoglobin, oxyhemoglobin, total hemoglobin, and hemoglobin saturation (hemoglobin-related parameters) within a tissue volume that is affected by changes in blood volume, flow velocity, and metabolic rate of oxygen (physiological parameters). For sinusoidal oscillatory changes, the phasor equations of the model provide the frequency dependence of the phase and amplitude of the phasors associated with hemoglobinrelated parameters (D, O, T, S) for a set of given phasors associated with the physiological parameters (
) [Eqs. (34)- (37)]. This model does not attempt to derive expressions for the physiological parameters and their relationships under specific physiological/functional/ pathologic conditions, but either takes them as known quantities on the basis of previous studies, or treats them as variables to identify their set of values that are consistent with experimental results for hemoglobin-related parameters. I now consider some relevant scenarios where the quantitative features of the model can help to investigate the underlying physiological processes and perform dedicated analyses of some of their features.
Pulse oximetry and spiroximetry
If the blood volume oscillations of either the arterial compartment (|v This is the basis for the measurements of arterial saturation by pulse oximetry at the heart-beat frequency (ω H ) (Franceschini et al., 1999; Wolf et al., 1997; Wukitsch et al., 1988) , and venous saturation by so-called spiroximetry at the respiratory frequency (ω R ) (Franceschini et al., 2002; Wolf et al., 1997) . In fact, according to point (3) above, for dominant contributions from arterial or venous volume oscillations, Eqs. (34) and (35) yield the following results, respectively:
Frequency-resolved spectral measurements of hemodynamic oscillations: coherent hemodynamics spectroscopy (CHS)
The model presented here provides a theoretical framework for a novel kind of frequency-resolved, spectral studies of cerebral hemodynamics and oxygenation. By properly designing protocols involving periodic brain stimulation, physiological challenges, or other kinds of active or passive physical maneuvers, one can measure the amplitude and phase of associated hemodynamic oscillations as a function of frequency. Furthermore, protocols designed to induce or enhance hemodynamic oscillations at a particular frequency can achieve a high level of coherence between the oscillations of physiological properties and the oscillations of hemoglobin concentration and saturation in tissue, for which the proposed approach based on transfer function analysis is especially suited. In fact, besides indicating a lack of correlation, low coherence values between physiological perturbations and observed hemoglobin-related tissue responses may reflect (1) a non-linear relationship, (2) a further dependence of the observed quantities on input variables not considered in the model, and/or (3) a significant contribution from observational or extraneous noise (Timmer et al., 1998) . All three of these conditions would negatively impact the accuracy of the model [points (1) and (2)] or the precision of the amplitude and phase measurements [point (3)]. Because of the relevance of a high level of coherence between physiological perturbations and the observed tissue hemoglobin concentration and saturation, I term this novel approach coherent hemodynamics spectroscopy (CHS), for which Eqs. (34)- (37) provide a quantitative and analytical description. The critical coherence value to reject the null hypothesis of zero coherence (which depends on the significance level of the statistical test and the equivalent number of degrees of freedom associated with the data acquisition and analysis procedure) typically assumes values between 0.1 and 0.3 (Halliday et al., 1995; Timmer et al., 1998; Winterhalder et al., 2006) . The requirement of a high level of coherence, as opposed to that of a non-zero coherence, translates into more stringent conditions associated with greater threshold coherence values. The role of high coherence levels in the analysis of hemodynamic oscillations in the low-frequency range (≲0.1 Hz) has been pointed out in studies of cerebral autoregulation (Hahn et al., 2011; Zhang et al., 1998) and functional brain activation (Obrig et al., 2000) , where coherence threshold values of~0.5 were considered.
Near-infrared spectroscopy affords separate measurements of the tissue concentration phasors of deoxy-hemoglobin (D) and oxy-hemoglobin (O), which combine into the phasors of total hemoglobin concentration (T) and tissue hemoglobin saturation (S). Fig. 3 shows the frequency spectra predicted by the model for the phase difference and amplitude ratio of D and O, and for the phase difference and amplitude ratio of O and T (as obtained by using the numerical values of Table 2 ). I observe that the stronger spectral variability of the amplitude ratio of O and T with respect to D and O [ Fig. 3(a) ] is mirrored by the weaker spectral variability of the phase difference of O and T with respect to D and O [ Fig. 3(b) ]. These spectral features carry information about systemic vs. local, static vs. dynamic, and anatomical/functional/metabolic parameters that affect tissue hemodynamics as described in the model. A number of relevant features of CHS spectra are further described in the companion article, which also reports experimental CHS spectra (and associated fits using the model presented here) collected with NIRS on the brain and calf muscle of human subjects (Pierro et al., 2014) .
By taking into account the dependence of the fMRI BOLD signal (S BOLD ) on the deoxy-hemoglobin content and the venous blood volume (Buxton et al., 1998; Obata et al., 2004) , one can also introduce a BOLD signal phasor (S BOLD ) in terms of the deoxy-hemoglobin concentration phasor D [Eq. (36) 
where I have introduced a combination of the contributions from arterial, capillary, and venous blood volumes (v , respectively). Eq. (40) shows that the fMRI BOLD signal can also be used to perform coherent hemodynamics spectroscopy (CHS), possibly in combination with measurements of cerebral blood flow [by perfusion MRI or arterial spin labeling (ASL)] or arterial blood pressure oscillations (by finger plethysmography).
Measurements of cerebral autoregulation
Cerebral autoregulation is the process that maintains a relatively constant cerebral blood flow over a range of cerebral perfusion pressures. It has been shown that cerebral autoregulation behaves as a high-pass filter for regulating cerebral blood flow velocity in response to changes in arterial blood pressure (Diehl et al., 1995; Zhang et al., 1998 ) with a high-pass cutoff frequency of~0.15 Hz (Blaber et al., 1997) . Consistent with such high-pass behavior, oscillations at~0.1 Hz in blood flow velocity (measured by transcranial Doppler ultrasound in the middle cerebral artery) lead oscillations in arterial blood pressure (measured by beat-to-beat finger plethysmography), with a phase angle that is reduced in the case of impaired autoregulation (Reinhard et al., 2006) . Pressure and flow velocity oscillations at a frequency of~0.1 Hz occur spontaneously (Cheng et al., 2012; Panerai et al., 1998) , but they can also be induced at a controlled frequency by paced breathing (Reinhard et al., 2006) , head-up-tilting (Hughson et al., 2001 ), squat-stand maneuvers (Claassen et al., 2009 ), or pneumatic thigh-cuff inflation (Aaslid et al., 2007) .
The magnitude of the relative changes in arterial blood pressure are comparable to those of the associated blood flow velocity changes (Panerai et al., 2001; Reinhard et al., 2006; Zhang et al., 2009) . By contrast, the relative changes in flow velocity are about 5 times greater than the relative changes in blood volume, as estimated by the relative changes in tissue hemoglobin concentration on the basis of the data presented in Reinhard et al. (2006) , Rowley et al. (2007) after considering that the total hemoglobin concentration in the adult human brain is~60 μM (Hallacoglu et al., 2012) . Since the oscillations reported in Reinhard et al. (2006) , Rowley et al. (2007) are at a frequency of 0.1 Hz, which is in the order of the cutoff frequency for autoregulation, the amplitude of flow velocity oscillations at high frequencies may be even greater than~5 times the amplitude of blood volume oscillations. It must be noted that the Grubb's exponent, which is the ratio between relative changes in cerebral blood volume and blood flow, has been found to assume a broad range of values from~0.40 (Grubb et al., 1974; Lee et al., 2001 ) to 0.23 (Cheung et al., 2001 ). These steady state Grubb's exponent values have been found to not necessarily represent transient conditions involving autoregulation or brain activation. For example, a value of 0.27 has been reported over a time window of 10-30 s post stimulus in the rat somatosensory cortex, with lower values approaching 0.2 at~10 s post stimulus (Mandeville et al., 1999b ) and getting as low as 0.1-0.2 after stimulation onset (Kida et al., 2007) . Furthermore, rather than considering cerebral blood flow, the present article considers blood flow velocity, which is associated with a modified Grubb's exponent that has been reported to be lower (0.13 vs. 0.30) than the standard Grubb's exponent (Leung et al., 2009 ). While, strictly speaking, the ratio between relative changes in flow and volume is not exactly given by the inverse of the Grubb's exponent (Leung et al., 2009) , the inverse of the modified (~0.13) and dynamic (~0.2) Grubb's exponents is consistent with the reported factor of ≳ 5 between flow velocity and blood volume changes associated with autoregulation. Therefore, one can write the following relationship between the blood volume phasor (v), which is directly linked to arterial blood pressure oscillations, and the corresponding flow velocity phasor (f (c) ) that results from cerebral autoregulation: , v (v) ) to take into account their individual relationships to the flow velocity phasor (f (c) ) associated with autoregulation. In fact, autoregulation typically occurs at the level of arterioles, which actively dilate or constrict to modulate cerebral vascular resistance through myogenic, shear-dependent, and metabolic responses (Carlson et al., 2008; Gabrielli et al., 2009 (Ch. 43) ). However, capillaries and venules also exhibit passive cross-sectional changes in response to arterial pressure changes, even though these effects on autoregulation are typically neglected because of the small contributions of capillaries and venules to the total flow resistance (Carlson et al., 2008) . For simplicity, here I have considered v to be the average of the arterial, capillary, and venous volume phasors, i.e., v = (
)/3, but unequal weights can of course be introduced for the three vascular compartments. The complex transfer function vs. frequency for the autoregulation RC high-pass Fig. 2 (dotted  line) . The model allows one to compute phasor diagrams for f (c) , D, and O (using Eqs. (41), (34), and (35), respectively) for any given phasor v as a function of frequency, so that one can visualize the frequency evolution of the phase and amplitude relationship among the various oscillatory quantities. Such phasor diagrams are shown in Fig. 4(a) for four different frequencies [ω / (2π) = 0.05, 0.15, 0.30, and 0.50 Hz], by using the above values for ω c (AutoReg) /(2π) (i.e., 0.15 Hz), k (i.e., 5), and the values in Table 2 for the other relevant model parameters. Fig. 4(b) shows the corresponding phasor diagrams in the absence of autoregulation [i.e., by setting H 
, with higher values of ω c (AutoReg) representing a more effective autoregulation (i.e., effective regulation of blood flow over a broader range of frequencies of blood pressure fluctuations). Fig. 5(b) shows that the effect of autoregulation is to decrease the phase lag of tissue concentrations of deoxy-hemoglobin vs. oxy-hemoglobin, i.e., the negative phase difference between D and O becomes smaller in absolute value. This result is true regardless of the cutoff frequencies of the low-pass responses associated with blood transit times in capillaries and venules, as shown by the three curves in Fig. 5(b) and associated blood transit times reported in the figure caption. In a study of the effect of hemodynamic impairment of autoregulation, Reinhard et al. found that autoregulation impairment was associated with a decrease (by~40°) in the phase lag of 0.1 Hz oscillations of deoxy-hemoglobin vs. oxy-hemoglobin concentrations in tissue (Reinhard et al., 2006) , which is consistent with the results of Fig. 5(b) . 
Functional brain studies
The model presented here approximates the low-pass effects associated with capillaries and venules using a first-order RC low-pass response [Eq. (B. 3)] and a time-shifted Gaussian response [Eq. (C.3)], respectively. The associated transfer functions are given in Eqs. (15) and (26), and their inverse Fourier transforms provide the following impulse responses for the RC low-pass filter:
[where H(t) is the Heaviside unit step function (H(t) = 0 for t b 0; H(t) = 1 for t ≥ 0)], and for the time-shifted Gaussian low-pass filter:
where I recall from Appendices B and C that τ (c) = t . These phasor diagrams have been generated using the numerical values listed in Table 2 for the model parameters.
Furthermore, this model can also be used to predict the fMRI BOLD response, i.e., the blood oxygenation level dependent signal S BOLD ð Þmea-sured in functional magnetic resonance imaging. In fact, S BOLD can be expressed in terms of the normalized voxel content of deoxy-hemoglobin [D(t) / D 0 , where D 0 is the tissue concentration of deoxy-hemoglobin at rest] and the normalized venous blood volume [1 + v (venous) (t)] (Buxton et al., 1998; Obata et al., 2004) that is considered here to include all partially deoxygenated blood in the arterial, capillary, and venous compartments as in Eq. (40): Fig. 6 ). The amplitudes of the perturbations in blood volume (2.0%), flow velocity (7.3%), and oxygen consumption (2.4%) in Fig. 6 are such that their relative amplitudes match those reported in (Mandeville et al., 1999b) , and correspond to a modified Grubb's exponent of 0.27. Fig. 6 , in conjunction with Eqs. (44)- (47), demonstrates how this model can predict fNIRS and fMRI signals in response to any given combination of physiological perturbations in blood volume, flow velocity, and oxygen consumption. Of course, while the simplistic choice for the physiological perturbations of Fig. 6 only allows for a qualitative interpretation of the results, some typical results of fNIRS and fMRI are reproduced. For example, reproduced results include the increase in T as a result of an increase in blood volume, the concurrent increase in O and decrease in D as a result of a dominant increase in blood flow velocity, and the initial overshoot (Krüger et al., 1996) and post-stimulus undershoot in the BOLD signal as a result of the delayed blood volume recovery (Mandeville et al., 1998) , even though other metabolic or activity-related factors not modeled here likely play a role in the post-stimulus undershoot (Buxton, 2012) . By contrast, it has been reported that a decrease in blood flow induced by either hypoxia (Cohen et al., 2002) or caffeine administration speeds up the BOLD signal, as opposed to the prediction of this model for which a decrease in flow velocity results in an increase in the low-pass time constant associated with blood transit time and thereby in a slower hemodynamics response. The vascular constriction associated with hypoxia and caffeine may, however, also increase the effectiveness of neurovascular coupling and speed up the hemodynamic perturbations (Behzadi and Liu, 2005) , and these factors are not considered in the simple application of this model using ideal square perturbations for flow velocity and oxygen consumption.
By using Eqs. (44)- (47), one can predict fNIRS and fMRI BOLD signals resulting from general brain-activation-induced perturbations in blood volume, flow velocity, and oxygen consumption, so that exponential flow velocity transients (Mandeville et al., 1999b) , or any other temporal shape of blood volume perturbations (independently in arterioles, capillaries, and venules), capillary flow velocity perturbations, and oxygen consumption perturbations can be considered. The companion article reports a comparison between the model predictions, and fNIRS and BOLD fMRI measurements reported in the literature for a given set of measured perturbations in blood volume, flow velocity, and oxygen consumption (Pierro et al., 2014) .
Discussion
Input and output parameters for the model
The model presented here requires the specification of 14 parameters as input, plus any additional physiological or functional relationship among them. A first set of seven parameters is related to steady state, baseline quantities, namely the hemoglobin concentration in blood, the Fåhraeus factor, the arterial saturation, the oxygen diffusion rate from microvasculature to tissue, and the blood volume fractions
, (7) ϕ (v) ]. A second set of two parameters is related to the low-pass frequency response associated with the blood transit times in the microvasculature [(8 
, (9) 
]. A third set of five parameters is related to dynamic changes in blood volume, blood flow velocity, and metabolic rate of oxygen [ (10) . The complete set of the input and output parameters (and their distribution among arterial, capillary, venous, and tissue compartments) is shown in Fig. 7 , which is a comprehensive block diagram of the hemodynamic model presented here.
The results of the model are weakly sensitive to the blood concentration in tissue and the arterial saturation, at least within ranges of normal physiological values. There is also a weak sensitivity to α _ O , for which even a large change from 0.4 to 1. To illustrate the sensitivity of the phase and amplitude spectra to the model parameters, I have considered twenty-two different sets of parameter values that are reported in the Inline Supplementary Table  S1 . As a result, one can estimate the sensitivity of the phase and amplitude spectra to the rate constant for oxygen diffusion (Inline Supplementary  Fig. S1 ), the arterial, capillary, and venous blood volume fractions (Inline Supplementary Fig. S2 ), the capillary and venous blood transit times (Inline Supplementary Fig. S3 ), the cutoff frequency for autoregulation (Inline Supplementary Fig. S4 ), the asymptotic flow-to-volume amplitude ratio (Inline Supplementary Fig. S5 ), and the amplitudes of arterial, capillary, and venous blood volume oscillations (Inline Supplementary Fig. S6 ).
The phase difference between D and O is a robust and consistent parameter, mostly affected by the capillary and venous partial volumes [Inline Supplementary Fig. S2(a) ], the blood transit times in the microcirculation [Inline Supplementary Fig. S3(a) volume fractions [Inline Supplementary Fig. S2(c) ] and autoregulation efficiency [Inline Supplementary Fig. S4(c) ] having the strongest effect on the zero-crossing frequency at which O and T are in phase. Finally, the spectra of the amplitude ratio |O|/|T| consistently feature a broad peak reaching a maximum value greater than one (which is not inconsistent with the phasor relationship T =O + D). The peak frequency is mostly sensitive to the venule blood transit time [Inline Supplementary Fig. S3(d)] and to autoregulation cutoff frequency [Inline Supplementary Fig. S4(d) ], whereas the peak value is mostly sensitive to autoregulation [Inline Supplementary Fig. S4(d) ] and the volume-toflow amplitude ratio [Inline Supplementary Fig. S5(d) ]. The companion article reports a comprehensive summary (in its Table 1 ) of the major spectral features discussed above, as well as their dependence on the hemodynamic model parameters (Pierro et al., 2014) . Inline Supplementary In summary, the dynamic model presented here allows one to quantitatively determine the dynamic features of the concentration and oxygen saturation of hemoglobin in tissue, in response to perturbations in blood volume (with separate contributions from arterial, capillary, and venous compartments), capillary flow velocity, and metabolic rate of oxygen, under given baseline conditions for the blood transit time in the microvasculature, oxygen consumption, and relative partial volumes of arterial, capillary, and venous blood.
Collective treatment of the microvasculature as a microvascular network
This model treats the arterioles, capillaries, and venules that comprise the tissue microvasculature as a complete network, without a need for any assumptions on the details of the architecture and morphology of such vascular network. In fact, the only premise of the model is that red blood cells, in their convective motion through the vasculature sequentially travel through an arterial, a capillary, and a venous compartment, and that oxygen exchange with the tissue occurs only in the capillary compartment. What matters for the model is the effective time that red blood cells spend in the capillary compartment, regardless of the details of the statistical distribution of such transit time over the red blood cell population as determined by narrowing, bifurcations, and merging of capillaries, non-laminar flow, etc. At the heart of the model lies this effective blood transit time through capillaries (t (c) = L
/c (c) ) and its associated probability of oxygen release to tissue of (1−e ) and venous (L (v) ) compartments may be longer than the physical length of the corresponding combined vascular segments. The role of the average blood transit time through the venous
/c (v) ) is to introduce a delay, or phase lag, to the tissue saturation changes associated with a change in the oxygen extraction factor (as determined by a change in either or both of t (c) and α _ O ). Such a phase lag is limited to less than~180°because of the strong amplitude attenuation of the associated Gaussian low-pass transfer function for greater phase delays (see Fig. 2 ). This approach results in a robust treatment of the complexity of the tissue microvasculature by the identification of the key issues of blood and oxygen transport through the vasculature that affect the overall tissue concentration and oxygen saturation of hemoglobin, which are the focus of this dynamic model.
Assumptions of the model
The low-pass effects associated with the blood transit time in the microvasculature, and the high-pass effects associated with autoregulation are treated here within the framework of transfer function analysis, which relies on the linearity and time-invariance between the input (perturbations in blood volume, flow-velocity, and oxygenconsumption) and the output (changes in tissue concentration and oxygen saturation of hemoglobin). In the case of small hemodynamic perturbations associated with brain activation or minor physiological challenges, the assumption of linearity is reasonable and typically satisfied. For example, total hemoglobin changes associated with brain activation (0.5-5%) (Ferrari and Quaresima, 2012; Lloyd-Fox et al., 2010; Wolf et al., 2008) , paced breathing (~3%) (Reinhard et al., 2006) , or spontaneous low-frequency oscillations (~3%) (Rowley et al., 2007) are small enough to justify a linear approximation. However, strong physiological perturbations or extreme conditions that are potentially associated with pathological states, may invalidate the linearity assumption and require the introduction of non-linear models. Even strong physiological perturbations such as the large changes in cerebral blood flow associated with brain activation (80-100% in the rat somatosensory cortex; Kida et al., 2007; Mandeville et al., 1999b ) may be treated within the framework of linear models provided that the resulting perturbations in the measured signals (fMRI BOLD, NIRS intensity) are small and feature a monotonic dependence on them. While linear models were found to be sufficient to describe brain activation maps (Deneux and Faugeras, 2006) and are applicable to small physiological perturbations, one should consider steps to validate the assumption of linearity in the particular application considered. Time invariance is likely fulfilled when considering measurements over times that are short compared to the time scale of changes for underlying physiological conditions. Phase and amplitude measurements of hemodynamic oscillations require a good signal-to-noise ratio that, together with the linearity between input and output signals, results in a high coherence between the perturbations in physiological quantities and the changes in tissue concentration/saturation of hemoglobin. The requirement of a high coherence between the input and output signals may not be fulfilled in the presence of weak and highly variable oscillations (as may be the case of spontaneous low-frequency oscillations) or in the case of non-linear regimes, but it is usually fulfilled by regular oscillations induced by periodic maneuvers such as paced breathing (Reinhard et al., 2006) , head-up-tilting (Hughson et al., 2001) , squat-stand maneuvers (Claassen et al., 2009 ), or pneumatic thigh-cuff inflation (Aaslid et al., 2007) . In the case of cerebral autoregulation, several groups have proposed nonlinear analysis (Mitsis et al., 2002) and wavelet transforms (Latka et al., 2005; Peng et al., 2010) to refine the predictions of linear transfer function analysis, and these approaches may also benefit the model presented here, especially when considering lowcoherence hemodynamic fluctuations. In addition to the above considerations, the phasor representation of Eqs. (34)- (37), (40) requires that the oscillations under consideration have a well-defined frequency and a sinusoidal shape. This condition may be attained by proper band-pass filtering of the data or by proper experimental design in the case of protocols involving periodic stimulation, physiological challenges, or other kinds of physical maneuvers, but it is nevertheless an approximation in the study of biological tissue in vivo.
Deoxy-hemoglobin oscillations lag oxy-hemoglobin oscillations at low frequencies (~0.1 Hz)
The model provides a quantitative description for the phase lag of deoxy-hemoglobin concentration oscillations (described by the phasor D) with respect to oxy-hemoglobin concentration oscillations (described by the phasor O) that have been reported in NIRS studies of spontaneous low frequency oscillations (Lee et al., 2010; Obrig et al., 2000; Pierro et al., 2012; Taga et al., 2000; Tian et al., 2011) and paced-breathing-induced oscillations (Obrig et al., 2000; Reinhard et al., 2006) at frequencies of 0.1 Hz. From the model, it follows that at these low frequencies of oscillation deoxy-hemoglobin always lags oxy-hemoglobin, so that an apparent phase lead of D vs. O by a certain angle θ should really be interpreted as a phase lag by 2π − θ. The reason can be seen by inspection of Eqs. (34) and (35), and by considering that the low-pass effect of the blood transit time in the vasculature on the hemoglobin saturation [Eqs. (16) , (17), (27), (28)] and the high-pass effect of autoregulation for the blood flow velocity [Eq. (41)] both result in a decrease with frequency of the phase of the second term in the bracket of Eqs. (34) and (35) (see Fig. 2(b) for the frequency dependence of the phase of the RC low-pass, RC high-pass, and Gaussian transfer functions). As a result, D and O are in phase at zero frequency (because f (c) = 0 at zero frequency) and grow out of phase as frequency increases. Because the second phasor in the bracket has the same magnitude in Eq. (35) for O and in Eq. (34) for D, and the first phasor in the bracket (the blood volume phasor) has a greater magnitude in Eq. (35) for O than in Eq. (34) for D, it follows that the phase of D decreases with frequency at a faster rate than the phase of O (the phase of O may even increase with frequency at very low frequencies as a result of the high-pass, positive phase contribution of autoregulation), with the net result that the difference between the phase of D and the phase of O becomes more and more negative as frequency increases (this is generally true as long as relative changes in flow velocity are larger than relative changes in blood volume as observed in response to hypoxia/hyperoxia (Grubb et al., 1974 ) and brain activation (Mandeville et al., 1999b) ). The result that deoxy-hemoglobin oscillations lag oxy-hemoglobin oscillations in the low-frequency band stems from the fact the flow-induced oxy-hemoglobin oscillations (O F ) lag the flow velocity oscillations (f (c) ) that cause them [see Eqs. (18) and (29)]. This means that even in the complete absence of autoregulation (i.e., in-phase blood volume and flow velocity oscillations), one would expect a phase lag of D with respect to O at frequencies in the order of the low-pass cutoff frequencies associated with the blood transit time in the microvasculature (~0.3-0.6 Hz for the model parameters reported in Table 2 ). This result leads to a refinement of our previous approach to the study of the oscillatory components of deoxy-and oxy-hemoglobin concentration in tissue. In fact, while the combination of different physiological processes that are out-of-phase with respect to each other would certainly result in out-of-phase oscillations of deoxy-and oxy-hemoglobin oscillations (Zheng et al., 2010) , this model shows that even in-phase physiological processes may lead to phase-shifted measurements of deoxyand oxy-hemoglobin phasors at relatively low frequencies. Furthermore, our previous assumption [see Eqs. (18) and (29)].
Conclusions
The study of the spatial and temporal features of the effects of brain activation on cerebral hemodynamics and oxygenation is a primary focus of hemodynamic-based neuroimaging techniques such as fNIRS and fMRI. The dynamic model presented here provides a tool to translate a given set of activation-induced perturbations in the cerebral blood volume, flow velocity, and metabolic rate of oxygen into the concentration and oxygen saturation of hemoglobin in cerebral tissue. Such a tool can be used in the framework of two different scenarios. Firstly, it can be used to predict the cerebral hemodynamic and oxygenation response to given perturbations in the blood volume, flow velocity, and metabolic rate of oxygen. Secondly, it can be used to identify a set of perturbations in the blood volume, flow velocity, and metabolic rate of oxygen that is consistent with observed experimental results of hemodynamic-based neuroimaging techniques. The fact that hemodynamic-based neuroimaging techniques are indirectly sensitive to neural activation through its associated hemodynamic effects poses an intrinsic limitation to their spatial (Turner, 2002) and temporal (de Zwart et al., 2005) resolution, and this work quantifies the latter effect through the time constants t (c) and t (v) for blood transit in the capillary and venous vascular compartments, respectively. Spontaneous hemodynamic oscillations in the low frequency spectral band (≲ 0.1 Hz) have been extensively investigated to assess cerebral functional connectivity using fMRI (Biswal et al., 1995; Fox and Raichle, 2007; Greicius et al., 2003) , NIRS (Lu et al., 2010; Sasai et al., 2011; Sassaroli et al., 2012; White et al., 2009) , and both techniques combined (Duan et al., 2012) . The hemodynamic model presented here provides a novel tool for the quantitative study of periodic hemodynamic oscillations, provided that they exhibit a high level of coherence, which may or may not be the case for spontaneous hemodynamic oscillations. Furthermore, the presented hemodynamic model provides a theoretical framework for a novel technique to investigate a number of anatomical, functional, metabolic, and physiological quantities by inducing coherent hemodynamic oscillations at controlled frequencies. This novel technique, coherent hemodynamics spectroscopy (CHS), is based on measurements of the frequency spectra of the phase difference and amplitude ratio of oscillatory concentrations of oxy-hemoglobin and deoxy-hemoglobin in tissue, and the quantitative assessment of their relevant spectral features. Step response of average capillary saturation The time dependence of the average capillary saturation for 0 ≤ t ≤ L Appendix D. Transient capillary and venous saturation for a step change in oxygen consumption rate
Because blood flow velocity (c) and oxygen consumption rate (α _ O ) do not appear independently but are coupled in the ratio α _ O =c, the expressions for the transient saturation changes in response to a step change in oxygen consumption are formally the same as those for the step change in flow velocity, at least in the case of small perturbations. The asymptotic saturation step responses to velocity and oxygen consumption rate changes have the same magnitude and opposite signs (Fantini, 2002) . In other words, a 1% increase in c and a 1% decrease in α _ O result in steady-state average capillary and venous saturations that are higher than the corresponding initial values by the same amount. As a result, Eq. (B.3) also describes the average capillary saturation response to a step change in oxygen consumption rate (with the replacement of c 2 (c) with c
), and Eq. (C.3) also describes the average venous saturation response to a step change in oxygen consumption rate. Step response of average venous saturation 
